Journals / Turkish Journal of Pediatrics / 2021 / Cilt: 63 - Sayı: 5

Evaluation of retinal nerve fiber layer and choroidal thickness with spectral domain optical coherence tomography in children with sickle cell anemia

Pages
875–883
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Early diagnosis of retinopathy during subclinical disease will prevent visual loss in these patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim of this study is to examine the thickness of choroidal, macular and peripapillary retinal nerve fiber layer by spectral-domain optical coherence tomography (SD-OCT) in pediatric patients with sickle cell anemia (SCA) without retinopathy.
📊
Key Findings & Data:A total of 75 children (30 SCA patients (Group 1) and 45 healthy individuals (Group 2) were included in the study.
💡
Conclusion & Impact:Early diagnosis of retinopathy during subclinical disease will prevent visual loss in these patients.
🔬Design:Research Article
📍Scope:2000 Verileri
⚙️Variables:Domain Parameters

Özet

Background. The aim of this study is to examine the thickness of choroidal, macular and peripapillary retinal nerve fiber layer by spectral-domain optical coherence tomography (SD-OCT) in pediatric patients with sickle cell anemia (SCA) without retinopathy. Methods. A total of 75 children (30 SCA patients (Group 1) and 45 healthy individuals (Group 2) were included in the study. Macular (central, superior, inferior, nasal, temporal), choroidal (subfoveal, at nasal distances from the central fovea of 1000 μm [N1], 2000 μm [N2], 3000 μm [N3], at temporal distances from the central fovea of 1000 μm [T1], 2000 μm [T2], 3000 μm [T3]) and RNFL (average, temporal, superotemporal, inferotemporal, nasal, inferonasal and superonasal) measurements were performed by SD-OCT. These parameters were compared with healthy children with similar demographic characteristics. Results. The mean age was 14.11±3.86 (11-18) in sickle cell anemia patients and 13.15± 2.69 (10-18) in the healthy control group. Of the patients, 56.6% (n=17) of Group 1 and 44.4% (n=20) of Group 2 were male. Choroidal measurements made in the subfoveal, N1, N2, N3, T1, T2 and T3 quadrants showed that the choroid was thinner in 6 quadrants in SCA patients compared to the healthy group (p = 0.003, p = 0.039, p = 0.035, p = 0.595, p = 0.006, p = 0.005, p = 0.047, respectively). In RNFL measurements, there was significant thinning in the temporal, inferotemporal, and nasal quadrants of SCA patients compared to the healthy group. Changes in other quadrants were not significant. Conclusions. SD-OCT is a useful imaging method in the diagnosis and screening in patients with SCA without retinopathy. Early diagnosis of retinopathy during subclinical disease will prevent visual loss in these patients.

🔖

Cite This Article

YILMAZ, K., ÖNCÜL, H., ÜZEL, V. H., SÖKER, M., ÖNCEL, K., YILMAZ, E. D. (2021). Evaluation of retinal nerve fiber layer and choroidal thickness with spectral domain optical coherence tomography in children with sickle cell anemia. Turkish Journal of Pediatrics, Cilt: 63 - Sayı: 5, 875–883. https://ajindex.com/articles/411939

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Ünal S. Orak hücreli anemi tedavi ve izlem. Türk Hematoloji Derneği. HematoLog 2014; 4: 79-93
  2. Downes SM, Hambleton IR, Chuang EL, Lois N, Serjeant GR, Bird AC. Incidence and natural history of proliferative sickle cell retinopathy: observations from a cohort study. Ophthalmology 2005; 112: 1869-1875
  3. Fadugbagbe AO, Gurgel RQ, Mendonca CQ, Cipolotti R, dos Santos AM, Cuevas LE. Ocular manifestations of sickle cell disease. Ann Trop Paediatr 2010; 30: 19-26
  4. Elagouz M, Jyothi S, Gupta B, Sivaprasad S. Sickle cell disease and the eye: old and new concepts. Surv Ophthalmol 2010; 55: 359-377
  5. Moriarty BJ, Acheson RW, Condon PI, Serjeant GR. Patterns of visual loss in untreated sickle cell retinopathy. Eye (Lond) 1988; 2(Pt 3): 330-335
  6. Murthy RK, Grover S, Chalam KV. Temporal macular thinning on spectral-domain optical coherence tomography in proliferative sickle cell retinopathy. Arch Ophthalmol 2011; 129: 247-249
  7. Chow CC, Genead MA, Anastasakis A, Chau FY, Fishman GA, Lim JI. Structural and functional correlation in sickle cell retinopathy using spectral domain optical coherence tomography and scanning laser ophthalmoscope microperimetry. Am J Ophthalmol 2011; 152: 704-711
  8. Goldberg MF, Galinos S, Lee CB, Stevens T, Woolf MB. Editorial: macular ischemia and infarction in sickling. Invest Ophthalmol 1973; 12: 633-635
  9. Han IC, Tadarati M, Pacheco KD, Scott AW. Evaluation of macular vascular abnormalities identified by optical coherence tomography angiography in sickle cell disease. Am J Ophthalmol 2017; 177: 90-99
  10. Brasileiro F, Martins TT, Campos SB, et al. Macular and peripapillary spectral domain optical coherence tomography changes in sickle cell retinopathy. Retina 2015; 35: 257-263
  11. Hoang QV, Chau FY, Shahidi M, Lim JI. Central macular splaying and outer retinal thinning in asymptomatic sickle cell patients by spectral-domain optical coherence tomography. Am J Ophthalmol 2011; 151: 990-994.e1
  12. Cai CX, Han IC, Tian J, Linz MO, Scott AW. Progressive retinal thinning in sickle cell retinopathy. Ophthalmol Retina 2018; 2: 1241-1248.e2
  13. Ghasemi Falavarjani K, Scott AW, Wang K, et al. Correlation of multimodal imaging in sickle cell retinopathy. Retina 2016; 36(Suppl 1): S111-S117
  14. Do BK, Rodger DC. Sickle cell disease and the eye. Curr Opin Ophthalmol 2017; 28: 623-628
  15. Hood MP, Diaz RI, Sigler EJ, Calzada JI. Temporal macular atrophy as a predictor of neovascularization in sickle cell retinopathy. Ophthalmi